Clinical Trial Update: BCG-induced Epigenetic Modifications in the NEXT Generation [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring BCG-induced epigenetic modifications related to trained immunity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bcg Vaccine-related Effects
• Trained Immunity-related Conditions

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Trained Immunity, BCG Vaccine | Phase 4 | Status: UNKNOWN